JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2004; 43:576-582, doi:10.1016/j.jacc.2003.10.031
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sachdev, M.
Right arrow Articles by Jollis, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sachdev, M.
Right arrow Articles by Jollis, J. G.

CLINICAL RESEARCH

The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease

Molly Sachdev, MD, MPH*,*, Jie Lena Sun, MS*, Anastasios A. Tsiatis, PhD*, Charlotte L. Nelson, MS*, Daniel B. Mark, MD, MPH* and James G. Jollis, MD*

* Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA

Manuscript received October 21, 2002; revised manuscript received September 22, 2003, accepted October 7, 2003.

* Reprint requests and correspondence: Dr. Molly Sachdev, Duke University, Internal Medicine, 129 Forest Oaks, Durham, North Carolina 27705, USA.
mollysachdev{at}yahoo.com

OBJECTIVES: To identify the prevalent and prognostically important coexisting illnesses among single coronary artery disease (CAD) patients.

BACKGROUND: As the population ages, physicians are increasingly required to make decisions concerning patients with multiple co-existing illnesses (comorbidity). Many trials of CAD therapy have excluded patients with significant comorbidity, such that there are limited data to guide the management of those patients.

METHODS: To consider the long-term prognostic importance of comorbid illness, we examined a cohort of 1,471 patients with CAD who underwent cardiac catheterization between 1985 and 1989 and were followed up through 2000 in the Duke Databank for Cardiovascular Diseases. Weights were assigned to individual diseases according to their prognostic significance in Cox proportional hazards models, thus creating a new CAD-specific index. The new index was compared with the widely used Charlson index, according to prevalence of conditions, individual and overall associations with survival, and agreement.

RESULTS: The Charlson index and the CAD-specific index were highly associated with long-term survival and almost equivalent to left ventricular ejection fraction. When considering the components of the Charlson index, diabetes, renal insufficiency, chronic obstructive pulmonary disease, and peripheral vascular disease had greater prognostic significance among CAD patients, whereas peptic ulcer disease, connective tissue disease, and lymphoma were less significant. Hemiplegia, leukemia, lymphoma, severe liver disease, and acquired immunodeficiency syndrome were rarely identified among patients undergoing coronary angiography.

CONCLUSIONS: Comorbid disease is strongly associated with long-term survival in patients with CAD. These data suggest co-existing illnesses should be measured and considered in clinical trials, disease registries, quality comparisons, and counseling of individual patients.

Abbreviations and Acronyms
  AIDS = acquired immunodeficiency syndrome
  CAD = coronary artery disease
  CHF = congestive heart failure
  LVEF = left ventricular ejection fraction
  MI = myocardial infarction




This article has been cited by other articles:


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
A. B. Newman, R. M. Boudreau, B. L. Naydeck, L. F. Fried, and T. B. Harris
A Physiologic Index of Comorbidity: Relationship to Mortality and Disability
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2008; 63(6): 603 - 609.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. L. Sorror, S. Giralt, B. M. Sandmaier, M. De Lima, M. Shahjahan, D. G. Maloney, H. J. Deeg, F. R. Appelbaum, B. Storer, and R. Storb
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences
Blood, December 15, 2007; 110(13): 4606 - 4613.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. H. Halanych, M. M. Safford, W. C. Keys, S. D. Person, J. M. Shikany, Y.-I. Kim, R. M. Centor, and J. J. Allison
Burden of Comorbid Medical Conditions and Quality of Diabetes Care
Diabetes Care, December 1, 2007; 30(12): 2999 - 3004.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. G. Schneider, Y. Zhu, T. Coleman, and C. F. Semenkovich
Macrophage 3 Integrin Suppresses Hyperlipidemia-Induced Inflammation by Modulating TNF{alpha} Expression
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2699 - 2706.
[Abstract] [Full Text] [PDF]


Home page
DTBHome page
Stable angina who needs revascularisation?
DTB, February 1, 2007; 45(2): 12 - 16.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
K. Bindra, C. Berry, J. Rogers, N. Stewart, M. Watts, J. Christie, S.M. Cobbe, and H. Eteiba
Abnormal haemoglobin levels in acute coronary syndromes.
QJM, December 1, 2006; 99(12): 851 - 862.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. El-Sherif, W. E. Gooding, R. Santos, B. Pettiford, P. F. Ferson, H. C. Fernando, S. J. Urda, J. D. Luketich, and R. J. Landreneau
Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non-Small Cell Lung Cancer: A 13-Year Analysis
Ann. Thorac. Surg., August 1, 2006; 82(2): 408 - 416.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. H. Mehta, E. Honeycutt, E. D. Peterson, C. B. Granger, A. R. Halabi, L. K. Shaw, P. K. Smith, R. M. Califf, R. A. Harrington, and M. H. Sketch Jr
Impact of Internal Mammary Artery Conduit on Long-term Outcomes After Percutaneous Intervention of Saphenous Vein Graft
Circulation, July 4, 2006; 114(1_suppl): I-396 - I-401.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. N. Bairey Merz, L. J. Shaw, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, C. J. Pepine, S. Mankad, B. L. Sharaf, et al.
Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: Gender Differences in Presentation, Diagnosis, and Outcome With Regard to Gender-Based Pathophysiology of Atherosclerosis and Macrovascular and Microvascular Coronary Disease
J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S21 - S29.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
C. A Daly, B. De Stavola, J. L L. Sendon, L. Tavazzi, E. Boersma, F. Clemens, N. Danchin, F. Delahaye, A. Gitt, D. Julian, et al.
Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study
BMJ, February 4, 2006; 332(7536): 262 - 267.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. L. Sorror, M. B. Maris, R. Storb, F. Baron, B. M. Sandmaier, D. G. Maloney, and B. Storer
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
Blood, October 15, 2005; 106(8): 2912 - 2919.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y.W. Lew, J. Narula, D. Sahn, et al.
Highlights of the year in JACC 2004
J. Am. Coll. Cardiol., January 4, 2005; 45(1): 137 - 153.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.